G. Pandini, F. Frasca, R. Mineo, L. Sciacca, R. Vigneri, A. Belfiore (2002)
Insulin/Insulin-like Growth Factor I Hybrid Receptors Have Different Biological Characteristics Depending on the Insulin Receptor Isoform Involved*The Journal of Biological Chemistry, 277
A. Belfiore, G. Pandini, V. Vella, S. Squatrito, R. Vigneri (1999)
Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer.Biochimie, 81 4
N. Boute, K. Pernet, T. Issad (2001)
Monitoring the activation state of the insulin receptor using bioluminescence resonance energy transfer.Molecular pharmacology, 60 4
V. Vella, G. Pandini, L. Sciacca, R. Mineo, R. Vigneri, V. Pezzino, A. Belfiore (2002)
A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer.The Journal of clinical endocrinology and metabolism, 87 1
T. Issad, M. Combettes, P. Ferré (1995)
Isoproterenol inhibits insulin-stimulated tyrosine phosphorylation of the insulin receptor without increasing its serine/threonine phosphorylation.European journal of biochemistry, 234 1
A. Frattali, J. Treadway, J. Pessin (1992)
Transmembrane signaling by the human insulin receptor kinase. Relationship between intramolecular beta subunit trans- and cis-autophosphorylation and substrate kinase activation.The Journal of biological chemistry, 267 27
J. Gónzalez-Sánchez, M. Serrano-Ríos (2007)
Molecular basis of insulin action.Drug news & perspectives, 20 8
A. Denley, J. Wallace, L. Cosgrove, B. Forbes (2003)
The insulin receptor isoform exon 11- (IR-A) in cancer and other diseases: a review.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 35 11-12
P. Meyts, J. Whittaker (2002)
Structural biology of insulin and IGF1 receptors: implications for drug designNature Reviews Drug Discovery, 1
L. Sciacca, A. Costantino, G. Pandini, R. Mineo, F. Frasca, P. Scalia, P. Sbraccia, I. Goldfine, R. Vigneri, A. Belfiore (1999)
Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanismOncogene, 18
R. O’Connor (2003)
Regulation of IGF-I Receptor Signaling in Tumor CellsHormone and Metabolic Research, 35
V. Vella, L. Sciacca, G. Pandini, R. Mineo, S. Squatrito, R. Vigneri, A. Belfiore (2001)
The IGF system in thyroid cancer: new conceptsMolecular Pathology, 54
S. Nouaille, C. Blanquart, V. Zilberfarb, N. Boute, D. Perdereau, Johan Roix, A. Burnol, T. Issad (2006)
Interaction with Grb14 results in site‐specific regulation of tyrosine phosphorylation of the insulin receptorEMBO reports, 7
C. Blanquart, N. Boute, D. Lacasa, T. Issad (2005)
Monitoring the Activation State of the Insulin-Like Growth Factor-1 Receptor and Its Interaction with Protein Tyrosine Phosphatase 1B Using Bioluminescence Resonance Energy TransferMolecular Pharmacology, 68
N. Boute, S. Boubekeur, Danièle Lacasa, T. Issad (2003)
Dynamics of the interaction between the insulin receptor and protein tyrosine‐phosphatase 1B in living cellsEMBO reports, 4
G. Pandini, R. Vigneri, A. Costantino, F. Frasca, Antonio Ippolito, Y. Fujita‐Yamaguchi, K. Siddle, I. Goldfine, A. Belfiore (1999)
Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling.Clinical cancer research : an official journal of the American Association for Cancer Research, 5 7
S. Angers, A. Salahpour, Eric Joly, S. Hilairet, D. Chelsky, M. Dennis, M. Bouvier (2000)
Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET).Proceedings of the National Academy of Sciences of the United States of America, 97 7
F. Frasca, G. Pandini, P. Scalia, L. Sciacca, R. Mineo, A. Costantino, I. Goldfine, A. Belfiore, R. Vigneri (1999)
Insulin Receptor Isoform A, a Newly Recognized, High-Affinity Insulin-Like Growth Factor II Receptor in Fetal and Cancer CellsMolecular and Cellular Biology, 19
T. Issad, N. Boute, K. Pernet (2002)
A homogenous assay to monitor the activity of the insulin receptor using Bioluminescence Resonance Energy Transfer.Biochemical pharmacology, 64 5-6
M. Soos, Jonathan Whittaker, Richard Lammers, Axel Ullrich, K. Siddle (1990)
Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells.The Biochemical journal, 270 2
Hisanori Kato, T. Faria, B. Stannard, C. Roberts, D. Leroith (1994)
Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action.Molecular endocrinology, 8 1
T. Issad, N. Boute, S. Boubekeur, Danièle Lacasa (2005)
Interaction of PTPB with the insulin receptor precursor during its biosynthesis in the endoplasmic reticulum.Biochimie, 87 1
A. Moss, J. Livingston (1993)
Distinct beta-subunits are present in hybrid insulin-like-growth-factor-1 receptors in the central nervous system.The Biochemical journal, 294 ( Pt 3)
D. Moller, A. Yokota, J. Caro, J. Flier (1989)
Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man.Molecular endocrinology, 3 8
N. Boute, R. Jockers, T. Issad (2002)
The use of resonance energy transfer in high-throughput screening: BRET versus FRET.Trends in pharmacological sciences, 23 8
A. Frattali, J. Pessin (1993)
Relationship between alpha subunit ligand occupancy and beta subunit autophosphorylation in insulin/insulin-like growth factor-1 hybrid receptors.The Journal of biological chemistry, 268 10
Yao Xu, D. Piston, C. Johnson (1999)
A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins.Proceedings of the National Academy of Sciences of the United States of America, 96 1
M. Soos, K. Siddle (1989)
Immunological relationships between receptors for insulin and insulin-like growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors.The Biochemical journal, 263 2
L. Mosthaf, K. Grako, T. Dull, Lisa Coussens, A. Ullrich, D. McClain (1990)
Functionally distinct insulin receptors generated by tissue‐specific alternative splicing.The EMBO Journal, 9
(2000)
The ErbB signaling network: receptor heterodimerization in development and cancerThe EMBO Journal, 19
L. Ellis, E. Clauser, D. Morgan, M. Edery, R. Roth, W. Rutter (1986)
Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucoseCell, 45
M. Pollak, E. Schernhammer, S. Hankinson (2004)
Insulin-like growth factors and neoplasiaNature Reviews Cancer, 4
D. Lacasa, N. Boute, T. Issad (2005)
Interaction of the Insulin Receptor with the Receptor-Like Protein Tyrosine Phosphatases PTPα and PTPϵ in Living CellsMolecular Pharmacology, 67
Y. Yarden, M. Sliwkowski (2001)
Untangling the ErbB signalling networkNature Reviews Molecular Cell Biology, 2
M. Soos, C. Field, K. Siddle (1993)
Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity.The Biochemical journal, 290 ( Pt 2)
Molecular Pharmacology – Pubmed
Published: Dec 4, 2006
Access the full text.
Sign up today, get DeepDyve free for 14 days.